MIRA Pharmaceuticals, Inc.
MIRA
$1.41
-$0.01-0.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.08% | -3.84% | 58.54% | 43.03% | -33.58% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.05% | 74.89% | -90.53% | -81.15% | -18.29% |
| Change in Net Operating Assets | 11.64% | -529.23% | 116.61% | -69.10% | 152.03% |
| Cash from Operations | 7.43% | -55.31% | -74.40% | -4.59% | -30.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 101.44% | -- | 118.26% |
| Issuance of Common Stock | -- | -- | -- | -65.44% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -115.96% | -- | 100.00% | 103.29% | -91.52% |
| Cash from Financing | 103.65% | 113.99% | 313.87% | -58.41% | -76.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.50% | -51.47% | -3.62% | -77.40% | -3,099.57% |